Πλοήγηση ανά Θέμα "NUCLEAR-MEDICINE"

Αποτελέσματα 1-3 από 3

Patient-specific internal radionuclide dosimetry

Tsougos, I.; Loudos, G.; Georgoulias, P.; Theodorou, K.; Kappas, C. (2010)

The development of patient-specific treatment planning systems is of outmost importance in the development of radionuclide dosimetry, taking into account that quantitative three-dimensional nuclear medical imaging can be ...
A radionuclide dosimetry toolkit based on material-specific Monte Carlo dose kernels

Loudos, G.; Tsougos, I.; Boukis, S.; Karakatsanis, N.; Georgoulias, P.; Theodorou, K.; Nikita, K.; Kappas, C. (2009)

Objective We sought to develop a user-friendly dosimetry toolkit that should aid the improvement of the quality of radionuclide therapy, which is critically dependent on patient-specific planning of each treatment. Methods ...
Synthesis and structural characterization of neutral "3+2" oxorhenium and oxotechnetium complexes of the 2-mercaptoethyl-N-glycine (SNO)/2,2 '-bipyridine (NN) mixed ligand system

Giannopoulou, D. P.; Pirmettis, I.; Pelecanou, M.; Komiotis, D.; Sagnou, M.; Benaki, D.; Raptopoulou, C. P.; Terzis, A.; Papadopoulos, M. S. (2007)

Neutral. hexacoordinated "3 + 2" mixed ligand oxorhenium (1) and oxotechnetium (2) complexes of the general formula MO [SNO][NN]. where M = Re or Tc-99, SNO is 2-mercaptoethyl-N-glycine and NN is 2,2'-bipyridine (bpy), ...